HCV Care Pathway in Ile-de-France
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Number of patients effectively cared divided by number of patients eligible to care.
研究概览
简要总结
The main objective of this research is to evaluate a care pathway adapted to different category populations at risk of being infected with the hepatitis C virus in order to improve both the diagnosis turnaround times and the access to treatment. The aim is to allow a quick and effective access to diagnosis and treatment of HCV by strengthening the city hospital networks, access to early consultations and coordination of medical social actors.
详细描述
The current estimation of infected persons with chronic hepatitis C in France is over 200 ,000. It appears that prevention, screening, care management, medical and social care of patients can be significantly improved especially among the most vulnerable populations. Indeed, these new HCV infections are mediated by drug-using people, prisoners, migrants, men who have sex with men (MSM) and who are supported too late and without real access to treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years old and more
- •Positive Hepatitis C virus
- •Patient having expressed a non-objection to participate in this research
排除标准
- 未提供
结局指标
主要结局
Number of patients effectively cared divided by number of patients eligible to care.
时间窗: Year 3
次要结局
- Number of patients effectively treated divided by number of patients eligible to DAA treatment.(Year 3)
- Delay between HCV diagnosis and early consultation(Year 3)
- Number of patients cared in the HCV care pathway in Ile-de-France(Year 3)